当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Journal of Pharmaceutical and Biomedical Analysis杂志
Journal of Pharmaceutical and Biomedical Analysis
基本信息
期刊名称 Journal of Pharmaceutical and Biomedical Analysis
J PHARMACEUT BIOMED
期刊ISSN 0731-7085
期刊官方网站 https://www.sciencedirect.com/journal/journal-of-pharmaceutical-and-biomedical-analysis
是否OA No
出版商 Elsevier B.V.
出版周期 Semimonthly
文章处理费 登录后查看
始发年份 1983
年文章数 589
影响因子 3.1(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 CHEMISTRY, ANALYTICAL 分析化学2区
PHARMACOLOGY & PHARMACY 药学3区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 6.7 0.584 0.927
Chemistry
Spectroscopy
18/76 76%
Pharmacology, Toxicology and Pharmaceutics
Pharmaceutical Science
46/183 75%
Chemistry
Analytical Chemistry
40/156 74%
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
37/117 68%
Pharmacology, Toxicology and Pharmaceutics
Drug Discovery
52/157 67%
补充信息
自引率 6.5%
H-index 114
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0731-7085%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/JPBA/default.aspx
收稿范围
This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.

Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.

Papers dealing with the analytical aspects of traditional folk medicines are acceptable if the results are expected to attract the interest of readers also outside the area of origin, i.e. they have a focus on innovative analytical approaches. Regional differences in the phytochemical content of traditional folk medicine will not be considered. Manuscripts reporting on the analysis of novel phytochemicals will only be considered if their biological activity has been previously published in an international medium. Pharmacokinetic studies of traditional folk medicine will only be considered if only the identified components have been demonstrated to be solely responsible for the pharmacological activity.

Bioanalytical papers (pharmacokinetic, bioequivalence, protein and DNA binding studies) are accepted if the focus is on innovative analytical methodology. Manuscripts describing the pharmacokinetic profile of a single compound will not be considered for review. Pharmacokinetic studies will only be considered if they offer new profiles of a drug(s) and its metabolite(s) or new understandings of the mechanisms in drug disposition or response of existing drugs. Analytical studies on new investigational drugs that are currently in the preclinical phase are only acceptable if their pharmacological activity is well documented in an international medium.

Human subjects research must provide ethical approval and should include the name of the approving committee and the name of the institution and reference number where approval was granted. Animal studies must be approved from their Institutions Animal Care and Use Committee or any equivalent ethics committee accompanied by the reference number. For blood sampling procedures in rodents, retro-orbital bleeding will only be considered if a minimum of 7 days is allowed between repeat sampling. Furthermore, in the evaluation of the manuscript the editors reserve the right to determine whether the animal experimental technique is appropriate.

In determining the suitability of submitted articles for publication, particular scrutiny will be placed on the degree of novelty and significance of the research and the extent to which it adds to existing knowledge in pharmaceutical and biomedical analysis. In all submissions to the journal, authors must address the question of how their proposed methodology compares with previously reported methods. A substantial body of work cannot be fractionated into different shorter papers.
收录体裁
Reviews
Full Length Research Papers
Short Communications
投稿指南 https://www.sciencedirect.com/journal/journal-of-pharmaceutical-and-biomedical-analysis/publish/guide-for-authors
投稿模板
参考文献格式 https://www.elsevier.com/journals/journal-of-pharmaceutical-and-biomedical-analysis/0731-7085/guide-for-authors
编辑信息
Editors
Coral Barbas
University San Pablo CEU Center for Metabolomics and Bioanalysis, Boadilla del Monte, Spain 
Ivane Javakhishvili Tbilisi State University, T'bilisi, Georgia Submission address: Sepaserve GmbH, Johann-Krane-Weg 42, 48149 Münster, Germany
University of Florence, Firenze, Italy 

Markus Ganzera

University of Innsbruck, Innsbruck, Austria 
Mukogawa Women's University School of Pharmacy and Pharmaceutical Sciences Graduate School of Pharmacy and Pharmaceutical Sciences, Nishinomiya, Japan 

Shaoping Li

University of Macau, Taipa, Macao 

Ruin Moaddel

National Institute on Aging, Bethesda, Maryland, United States 

Sibel Ozkan

Ankara University, Ankara, Turkey 

Jean-Luc Veuthey

University of Geneva, Geneva, Switzerland 
Editorial Advisory Board

Steven Baertschi

Eli Lilly and Company, Indianapolis, Indiana, United States 

Carlo Bertucci

University Hospital of Bologna Sant'Orsola-Malpighi Polyclinic, Bologna, Italy 

Françoise Bressolle

University of Montpellier, Montpellier, France 

Francesco Busardò

Polytechnic University of Marche, Ancona, Italy 

Lukasz Ciesla

University of Alabama, Tuscaloosa, Alabama, United States 

Salvatore Fanali

University of Verona, Verona, Italy 

Szabolcs Fekete

Pharmacy College Geneva-Lausanne, Geneva, Switzerland 

Antonia Garcia

San Pablo CEU University, Boadilla, Spain 

Sándor Görög

Gedeon Richter Nyrt, Budapest, Hungary 

Roberto Gotti

University of Bologna, Bologna, Italy 

Kenji Hamase

Kyushu University, Fukuoka, Japan 

Brian L. He

Bristol-Myers Squibb Research New Brunswick, New Brunswick, New Jersey, United States 

Tatsuya Higashi

Tokyo University of Science - Noda Campus, Noda, Japan 

Emily Hilder

University of Tasmania, Hobart, Australia 

Ulrike Holzgrabe

University of Würzburg, Wurzburg, Germany 

Philippe Hubert

University of Liege, Liege, Belgium 

Zhengjin Jiang

Jinan University, Guangzhou, China 

Krzysztof Jozwiak

Medical University of Lublin, Lublin, Poland 

Michał Markuszewski

Medical University of Gdansk, Gdansk, Poland 

Laura Mercolini

University of Bologna, Bologna, Italy 

Reinhard H.H. Neubert

Martin Luther University Halle Wittenberg, Halle, Germany 

Regina Oliveira

Federal University of Sao Carlos, Sao Carlos, Brazil 

Bernard Olsen

Eli Lilly and Company, Indianapolis, Indiana, United States 

Serena Orlandini

University of Florence, Firenze, Italy 

Federica Pellati

University of Modena and Reggio Emilia, Modena, Italy 

Karen Phinney

National Institute of Standards and Technology, Gaithersburg, Maryland, United States

Simona Pichini

National Institute of Health, Roma, Italy 

Sergio Pinzauti

University of Florence, Firenze, Italy 

Serge Rudaz

Pharmacy College Geneva-Lausanne, Geneva, Switzerland 

Gerhard K.E. Scriba

Friedrich Schiller University Jena, Jena, Germany 

Kazutake Shimada

Kanazawa University, Japan

Saranjit Singh

National Inst. of Pharma. Education & Research, Dept. of Pharmaceutical Analysis, Punjab, India 

Shigeo Suzuki

Kindai University, Osaka, Japan 

Eva Szökö

Semmelweis University of Medicine, Budapest, Hungary 

Tung-Hu Tsai

National Yang Ming University Department of Chemical Engineering, Miaoli, Taiwan 

Ann Van Schepdael

KU Leuven Association, Leuven, Belgium 

Yvan Vander Heyden

VUB University, Brussel, Belgium 

Bastiaan Venhuis

National Institute of Public Health and the Environment, Bilthoven, Netherlands 

Ian D. Wilson

Imperial College London, London, United Kingdom 

Guowang Xu

Dalian Institute of Chemical Physics, Dalian, China 

Min Ye

Peking University, Beijing, China 


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug